Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6161 results
Lung cancer cells seen through a microscope.
  • Health & Medicine
  • Science & Technology

ASCO 2023 roundup: Blood tests, drugs and exercise

ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients. ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients.

12 June 2023

Senedd Cymru, or the Welsh Parliament.

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change. Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

by Tim Gunn | News | 8 June 2023

8 June 2023

Lung adenocarcinoma cells

Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers. Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers.

by Jacob Smith | Analysis | 1 June 2023

1 June 2023

a smoking cigarette

New analysis released on World No Tobacco Day by Cancer Research UK estimates that tobacco causes the death of one person every five minutes in the UK New analysis released on World No Tobacco Day by Cancer Research UK estimates that tobacco causes the death of one person every five minutes in the UK

by Amy Warnock | News | 31 May 2023

31 May 2023

  • For Researchers

Harnessing the power of CD3

Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out... Revolutionising our understanding of cancer risk using a huge variety of data to advance early detection of the disease – it sounds as ambitious as it is exciting, but is it possible? We caught up with Professor Antonis Antoniou to find out...

by Phil Prime | Interview | 30 May 2023

30 May 2023

This entry is part 8 of 37 in the series That Cancer Conversation
An elderly male patient sat on a hospital bed

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

by Jacob Smith | In depth | 29 May 2023

29 May 2023

Professor Silvia Formenti whets our appetite for all things radiotherapy. She tells us what excites her about the future of the field and why support for research is so important… Professor Silvia Formenti whets our appetite for all things radiotherapy. She tells us what excites her about the future of the field and why support for research is so important…

by Phil Prime | Interview | 26 May 2023

26 May 2023

Our Chief Executive

Our CEO Michelle Mitchell writes about how cancer care in the UK is a fixable problem, and outlines the important next steps to get to where we want to be Our CEO Michelle Mitchell writes about how cancer care in the UK is a fixable problem, and outlines the important next steps to get to where we want to be

by Michelle Mitchell | Opinion | 23 May 2023

23 May 2023

Andrea receiving chemotherapy.

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

by Tim Gunn | In depth | 22 May 2023

22 May 2023

From physical changes to emotional responses, here are 5 ways cancer can impact sexual wellbeing, and how they can be managed. From physical changes to emotional responses, here are 5 ways cancer can impact sexual wellbeing, and how they can be managed.

by Sophie Wedekind | Analysis | 17 May 2023

17 May 2023

A magnified image of squamous cell carcinoma, the most common type of cervical cancer

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

by Tim Gunn | News | 16 May 2023

16 May 2023